No Data
No Data
Vericel Corporation's (NASDAQ:VCEL) Business Is Trailing The Industry But Its Shares Aren't
There wouldn't be many who think Vericel Corporation's (NASDAQ:VCEL) price-to-sales (or "P/S") ratio of 9.8x is worth a mention when the median P/S for the Biotechs industry in the United States is si
Vericel(VCEL.US) Officer Sells US$1.53 Million in Common Stock
$Vericel(VCEL.US)$ Officer Colangelo Dominick sold 35,000 shares of common stock on Jun 12, 13, 2024 at an average price of $43.61 for a total value of $1.53 million.Source: Announcement What is state
Vericel Insider Sold Shares Worth $1,526,350, According to a Recent SEC Filing
Dominick Colangelo, Director, President and CEO, on June 12, 2024, sold 35,000 shares in Vericel (VCEL) for $1,526,350. Following the Form 4 filing with the SEC, Colangelo has control over a total of
Form 144 | Vericel(VCEL.US) Officer Proposes to Sell 754.22K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 13, $Vericel(VCEL.US)$ Officer Colangelo Dominick intends to sell 17,500 shares of its common stock on Jun 13, with a total market value of approximately $754.22K. Colang
Form 144 | Vericel(VCEL.US) Officer Proposes to Sell 772.02K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Vericel(VCEL.US)$ Officer Colangelo Dominick intends to sell 17,500 shares of its common stock on Jun 12, with a total market value of approximately $772.02K. Colang
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
CAMBRIDGE, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President
No Data